As part of the Mycobacteria Research Laboratories, the Avanzi Lab specializes in the genomics epidemiology of leprosy. More specifically, it investigates the transmission and dissemination dynamics of Mycobacterium leprae and Mycobacterium lepromatosis, the causative agents of leprosy in humans, along with the role of animal and environmental hosts in facilitating the global pathogen spread. Furthermore, her research encompasses the development and optimization of molecular diagnostic techniques for detecting these pathogens in clinical specimens and assessing their viability, which is crucial for evaluating treatment effectiveness and developing new regimens. Additionally, as a participant in the World Health Organization’s drug resistance surveillance network, her laboratory conducts comprehensive molecular analyses to determine drug susceptibility profiles and elucidate novel resistance mechanisms in M. leprae.
People
news and updates view all
Dr. Charlotte Avanzi discusses her 10-year history of leprosy research and why the bacteria responsible for the disease fascinates her.
The first World Leprosy Day Symposium was organized by the Mycobacterium Research Labs at Colorado State University.
An international team has identified leprosy in wild chimpanzees in the West African countries of Guinea-Bissau and Ivory Coast.
contact information
Lab: Microbiology Building room B330
Offices: Microbiology Building rooms B308 & B320
(970) 491-2669
[email protected]